1. Объем резюме увеличить минимум до 1000 знаков с пробелами



жүктеу/скачать 40.44 Kb.
бет3/3
Дата26.11.2022
өлшемі40.44 Kb.
#465822
1   2   3
Агабабян И Р и Ризаев Ж А исправ 1

Литература:

  1. Aarabi G, Zeller T, Seedorf H, Reissmann DR, Heydecke G, Schaefer AS, Seedorf U. Genetic susceptibility contributing to periodontal and cardio‑ vascular disease. J Dent Res. 2017;96:610–7.

  2. Agababyan I. R., Ismoilova Yu. A. Effectiveness of outpatient monitoring of patients with chronic heart failure // Achievements of science and education. - 2022. - p. 99.

  3. Agababyan I. R., Yarasheva Z. Kh. Echocardiography in predicting early chronic heart failure in elderly patients // Achievements of science and education. - 2022. - p.103-108.

  4. AGABABYAN I., AKHATOVA V., ISMOILOVA YU. CYTOKINE STATUS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE //Eurasian Journal of Medical and Natural Sciences. - 2022. - Vol. 2. - No. 6. - p. 90-94.

  5. Agababyan I., Solieva S., Ismoilova Yu. Condition of the coronary arteries and lipid profile changes in coronary heart disease // Annals of the Romanian Society of Cell Biology. - 2021. - p. 207-213.

  6. Agababyan I.R., Yarasheva Z.H. "Comparative evaluation of oral anticoagulants in the non-valvular form of atrial fibrillation" Problems of biology and medicine. 2021.No.4(129) 15-16 p.

  7. Agababyan I.R., Yarasheva Z.H., Mukhamedova M.G., Ruzieva A.A. “The diagnostic value of rutine research methods elektrokardiography and echocardiography in patients with chronic heart failure elderly” International Conference “Process Management and Scientific Developments” 2019/ 85-87 page

  8. Agababyan I.R., Yarasheva Z.H., Toshnazarova N.S., ToshnazaroV S.M. evaluation of the effectiveness of the combined use of angiotensin ii receptor antagonists and cardiac glycosides in the treatment of hypertension complicated by stage ii b chronic heart failure. "Achievements of Science and Education" No. 1 (81), 2022.pp. 88-90.

  9. Ainamo J, Bay I. Problems and proposals for recording gingivitis and plaque. Int Dent J. 1975;25(4):229–35.

  10. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640–5.

  11. Alfredsson J, Nelly B, Nelly ML, Bhatt DL, Goldman SG, Tricoci P, Mahafey KW, Cornel JH, White HD, Fox KAA, Prabhakaran D, Winters KJ, Arm‑ strong PW, Ohman M, Roe MT. Predicting the risk of bleeding dur‑ ing dual antiplatelet therapy after acute coronary syndromes. Heart. 2017;103:1168–76.

  12. Alimdzhanovich R.Yu., Rubenovna A.I., Abduvohidovna I.Yu. SPECIALIZED CENTER FOR PATIENTS WITH CHRONIC HEART FAILURE-LIFE EXTENSION //Questions of Science and Education. – 2021. – no. 22(147). - S. 14-24.

  13. Arnold M., Miller F. Congestive Heart Failure in the Elderly [Электронный ресурс] //2021. Режим доступа: http://www.ccs.ca/download/consensus_conference/consensus_conference_archives/2021_05.pdf. [Дата обращения: 12.02.2021].

  14. Beck JD, Garcia R, Heiss G, Vokonas PS, Ofenbacher S. Periodontal disease and cardiovascular disease. J Periodontol. 1996;67:1123–37.

  15. Beck JD, Heiss G, Madianos P, Couper D, Lin D, Moss K, Elter J, Ofen‑ bacher S. Periodontal disease and coronary heart disease. Circulation. 2005;112:19–24.

  16. Benjamin RM. Oral health: the silent epidemic. Public Health Rep. 2010;125(2):158–9. https://doi.org/10.1177/003335491012500202.

  17. Bokhari SA, Khan AA, Butt AK, Hanif M, Izhar M, Tatakis DN, Ashfaq M. Peri‑ odontitis in coronary heart disease patients: strong association between bleeding on probing and systemic biomarkers. J Clin Periodontol. 2014;41:1048–54.

  18. Bridge KI, Philippou H, Ariëns R. Clot properties and cardiovascular disease. Thromb Haemost. 2014;112:901–8.

  19. Calabro P, Golia E, Yeh ET. CRP and the risk of atherosclerotic events. Semin Immunopathol. 2009;31:79–94.

  20. Caton JG, Armitage G, Berglundh T, et al. A new classifcation scheme for periodontal and peri-implant diseases and conditions—introduc‑ tion and key changes from the 1999 classifcation. J Clin Periodontol. 2018;45(Suppl 20):S1–8. https://doi.org/10.1111/jcpe.12935.

  21. Cervino G, Fiorillo L, Monte IP, De Stefano R, Laino L, Crimi S, Bianchi A, Herford AS, Biondi A, Cicciù M. Advances in antiplatelet therapy for dentofacial surgery patients: focus on past and present strategies. Materi‑ als. 2019;2(9):1524.

  22. Danesh J, Collins R, Appleby P, Peto R. Association of fbrinogen, C-reac‑ tive protein, albumin, or leukocyte count with coronary heart disease. JAMA. 1998;279(18):1477.

  23. Folwaczny M, Wilberg S, Bumm C, Hollatz S, Oberhofer R, Neidenbach RC, Kaemmerer H, Frasheri I. Oral health in adults with congenital heart disease. J Clin Med. 2019;8(8):1255.

  24. Gillum RF, Ingram DD, Makuc DM. White blood cell count, coronary heart disease, and death: The NHANES I Epidemiologic Follow-up Study. Am Heart J. 1993;125(3):855–63.

  25. Górski B, Nargiełło E, Opolski G, Ganowicz E, Górska R. The association between dental status and systemic lipid profle and infammatory mediators in patients after myocardial infarction. Adv Clin Exp Med. 2016;25(4):625–30.

  26. Grant MM, Jönsson D. Next generation sequencing discoveries of the nitrate-responsive oral microbiome and its efect on vascular responses. J Clin Med. 2019;8(8):1110.

  27. Hujoel PP, Drangsholt M, Spiekerman C, DeRouen TA. Periodontal disease and coronary heart disease risk. JAMA. 2000;284:1406–10.

  28. Ishikawa I. Host responses in periodontal diseases: a preview. Periodontol. 2000;2007(43):9–13.

  29. Lang RM, Badano LP, Mor-Avi V, Aflalo J, Armstrong A, Ernande L, Flach‑ skampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt JU. Recom‑ mendations for cardiac chamber quantifcation by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardi‑ ogr. 2015;28:1–39.

  30. Lange DE, Plagmann HC, Eenboom A, Promesberger A. Clinical methods for the objective evaluation of oral hygiene. Deutsche Zahnärztliche Zeitschrift. 1977;32:44–7.

  31. Li C, Lv Z, Shi Z, Zhu Y, Wu Y, Li L, Iheozor-Ejiofor Z. Periodontal therapy for primary or secondary prevention of cardiovascular disease in people with periodontitis. Cochrane Database Syst Rev. 2019;12:CD009197.

  32. Lockhart PB, Bolger AF, Papapanou PN, Osinbowale O, Trevisan M, Levison ME, Taubert KA, Newburger JW, Gornik HL, Gewitz MH, Wilson WR, Smith SC Jr, Baddour LM. American Heart Association Rheumatic Fever, Endo‑ carditis, and Kawasaki Disease Committee of the Council on Cardiovas‑ cular Disease in the Young, Council on Epidemiology and Prevention, Council on Peripheral Vascular Disease, and Council on Clinical Cardiol‑ ogy. Periodontal disease and atherosclerotic vascular disease: Does the evidence support an independent association?: a scientifc statement from the American Heart Association. Circulation. 2012;125(20):2520–44.

  33. Lubrano V, Balzan S. Consolidated and emerging infammatory markers in coronary artery disease. World J Exp Med. 2015;5:2–32.

  34. Marfl-Álvarez R, Mesa F, Arrebola-Moreno A, Ramírez-Hernández JA, Magán-Fernández A, O’Valle F, Galindo-Moreno P, Catena A. Acute myo‑ cardial infarct size is related to periodontitis extent and severity. J Dent Res. 2014;93(10):993–8.

  35. Miśkiewicz A, Szparecki G. Periodontitis as a risk factor in cardiovascular diseases. Dent Med Probl. 2010;47(4):472–7.

  36. Mukhamedova M.G., Agababyan I.R., Yarasheva Z.H., Ruzieva A.A. Predictor significance of EchoCG and determination of the concentration of cerebral natriuretic peptide in elderly patients with chronic ischemic heart failure with preserved systolic function of the left ventricle. Science and innovation are modern concepts. 2019. p. 80-82.

  37. Nasretdinova M. T., Khayitov A. A., Normuradov N. A. The state of microbiocinosis in patients with cystic lesions of the maxillary sinuses // Otorhinolaryngology. Eastern Europe. - 2021.- T.11.- No. 2. - S. 169-174.

  38. Nasretdinova, M., Utemuratova, G., Dawletmuratov, A., Matveev, A., Kaigorodov, D., Kalinin, E., Mustaev, O., 2021. Advances in Biomimetics in Imitation of the Laws of Nature. JBBBE. https://doi.org/10.4028/www.scientific.net/jbbbe.53.77

  39. Nazir MA. Prevalence of periodontal disease, its association with systemic diseases prevention. Int J Health Sci (Qassim). 2017;11(2):72–80.

  40. Ndrepepa G, Braun S, Tada T, King L, Cassese S, Fusaro M, Keta D, Kastrati A, Schmidt R. Comparative prognostic value of C-reactive protein & fbrinogen in patients with coronary artery disease. Indian J Med Res. 2014;140:392–400. 26. Anitha G, Nagaraj M, Jayashree A. Comparative evaluation of levels of C-reactive protein and PMN in periodontitis patients related to cardiovas‑ cular disease. J Indian Soc Periodontol. 2013;17:330–3.

  41. Neumann F-J, Sousa-Uva M, Ahlsson A, Alfonso F, Banking AP, Bened‑ etto U, Byrne RA, Collet J-P, Falk V, Head SJ, Jüni P, Kastrati A, Koller A, Kristensen SD, Niebauer J, Richter DJ, Seferovic PM, Sibbing D, Stefanii GG, Windecker S, Yadav R, Zembala MO. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40:87–165.

  42. Ninomiya JK, L’Italien G, Criqui MH, Whyte JL, Gamet A, Chen RS. Associa‑ tion of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation. 2004;109(1):42–6.

  43. Nowbar AN, Howard JP, Finegold JA, Asaria P, Francis DP. Global geo‑ graphic analysis of mortality from ischaemic heart disease by country, age and income: statistics from World Health Organisation and United Nations. Int J Cardiol. 2014;174(2):293–8.

  44. Oscarsson J, Johansson A. Periodontitis: from dysbiotic microbial immune response to systemic infammation. J Clin Med. 2019;8(10):1706.

  45. Paraskevas S, Huizinga JD, Loos BG. A systemic review and meta-analyses in C-reactive protein in relation to periodontitis. J Clin Periodontol. 2008;35:277–90.

  46. Park SY, Kim SH, Kang SH, Yoon CH, Lee HJ, Yun PY, Youn TJ, Chae IH. Improved oral hygiene care attenuates the cardiovascular risk of oral health disease: a population-based study from Korea. Eur Heart J. 2019;40:1138–45.

  47. Patel MR, Bailey SR, Bonow RO, Chambers CE, Chan PS, Dehmer GJ, Kirtane AJ, Wann LS, Ward RP. CCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/ HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diag‑ nostic catheterization: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovas‑ cular Angiography and Interventions, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiog‑ raphy, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2012;59(22):1995–2027.

  48. Rich M. W. Heart failure in the 21 st century: a cardiogeriatric syndrome // J Gerontol A Biol Sci Med Sci. 2020. Vol. 56, № 2. P. 88–96.

  49. Rizaev Yu.A., Agababyan I.R., Ismoilova Yu.A. "Activities of clinics specializing in the treatment of patients with chronic heart disease in the world (links)". Journal of Biomedicine and Practice 6.6 (2021): 184-191.

  50. Rizaev Zh.A., Agababyan I.R., Yarasheva Z.H., Mukhamedova M.G. the significance of comorbid conditions in the development of chronic heart failure in elderly and senile patients., "Achievements of Science and Education" No. 1 (81), 2022.pp. 75-78.

жүктеу/скачать 40.44 Kb.

Достарыңызбен бөлісу:
1   2   3



©dereksiz.org 2024
әкімшілігінің қараңыз
    Басты бет